It has been reported that calcium deposition and calcium content in cultured human aortic smooth muscle cells (SMC) increased when the cells are incubated in a medium with a high phosphate concentration (2 mM). To determine the cellular components or soluble factors contributing to the deposition, we cultured commercially available SMC, fibroblasts (Fb) and endothelial cells (Ed). These cells and their mixtures were incubated for 10 days in normal or high-phosphate media. Calcium crystals were stained by the von-Kossa staining and counted in the defined area. Calcium content was measured by a colorimetric assay. SMC were incubated in high-phosphate media (up to 2 mM) or β-glycerophosphate (β-GP) media, resulting in no obvious deposition of calcium crystals, irrespective of the coating of type I collagen on the dish. Next, various combinations of cells were cultured, and a significant number of depositions were observed only when Fb were included in the combination. The calcium content was significantly higher in cultures of SMC and Fb. The calcium deposition on single or mixture of the cells did not increase compared with control when cells were incubated in a high concentration of phosphate, cultured in the existence of β-GP or uremic serum. We therefore conclude that Fb, rather than SMC or Ed, are essential for calcium deposition and calcium accumulation in culture. Phosphate concentration in the medium and uremic serum did not influence the deposition of calcium.

Keywords:
Vascular calcification, Fibroblasts, Smooth muscle cells, von-Kossa, Calcium deposition
1.
Kurihara S, Suga M: Risk factors on renal osteodystrophy and metastatic calcification in patients with long-term dialysis. Rinshyou Touseki 2000;16:1011–1019.
2.
Blumenthal HT, Lansing AI, Wheeler PA: Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, aging and disease. Am J Pathol 1944;20:665–687.
3.
Yu SY: Calcification processes in atherosclerosis. Adv Exp Med Biol 1974;43:403–425.
4.
Moon JY: Factors affecting arterial calcification associated with atherosclerosis. Atherosclerosis 1972;16:119–126.
5.
Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800–1809.
6.
Shanahan CM, Cary NRB, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994;93:2393–2402.
7.
Fitzpatrick LA, Severson A, Edwards WD, Ingram RT: Diffuse calcification in human coronary arteries: Association of osteopontin with atherosclerosis. J Clin Invest 1994;94:1597–1604.
8.
Shanahan CM, Proudfoot D, Tyson KL, Cary NRB, Edmonds M, Weissberg PL: Expression of mineralisation-regulating proteins in association with human vascular calcification. Z Kardiol 2000;89(suppl 2):63–68.
9.
Nakayama T, Ohtsuru A, Enomoto H, Ozeki S, Shibata Y, Yokota T, Nobuyoshi M, Ito M, Sekine I, Yamasita S: Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem Biophys Res Commun 1994;200:1028–1035.
10.
Jono S, Nishizawa Y, Shioi A, Mori H: 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998;98:1302–1306.
11.
Smith LL, Johnson BH: Biological activities of oxysterols. Free Rad Biol Med 1989;7:285–332.
12.
Hodis HN, Crawford DW, Sevanian A: Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: Further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991;89:117–126.
13.
Shanahan CM, Proudfoot D, Tyson KL, Cary NR, Edmonds M, Weissberg PL: Expression of mineralisation-regulating proteins in association with human vascular calcification. Z Kardiol 2000;89(suppl 2):63–68.
14.
Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:e10–e17.
15.
Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H: β-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995;15:2003–2009.
16.
Gitelman HJ: An improved automated procedure for determination of calcium in biological specimens. Anal Biochem 1967;18:521–531.
17.
Anderson HC: Molecular biology of matrix vesicles. Clin Orthop 1995;314:266–280.
18.
Kim KM: Matrix vesicle calcification of rat aorta millipore chambers. Met Bone Dis Rel Res 1978;1:213–217.
19.
Ashizawa N, Kristof G, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan T, Hsueh WA: Osteopontin is produced by rat cardiac fibroblasts and mediates A-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996;98:2218–2227.
20.
Boskey AL, Stiner D, Binderman I, Doty SB: Type I collagen influences cartilage calcification: An immunoblocking study in differentiating chick limb-bud mesenchymal cell cultures. The Hospital for Special Surgery, New York, New York 10021, USA. J Cell Biochem 2000;79:89–102.
21.
Hui M, Li SQ, Holmyard D, Cheng P: Stable transfection of nonosteogenic cell lines with tissue nonspecific alkaline phosphatase enhances mineral deposition both in the presence and absence of beta-glycerophosphate: Possible role for alkaline phosphatase in pathological mineralization. Calcif Tissue Int 1997;60:467–472.
22.
Yin T, Linda LD: Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001;12:555–560.
23.
Schwarz G, Laukhuf F, Bittinger F, Knop J, Saloga J: Calciphylaxis: Ischemic tissue necrosis in chronic renal failure. Case report and review of the literature. Hautarzt 2000;51:36–40.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.